Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
DRUG
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.08
vs -1.89
Q2.23
N/A
-0.29
vs -1.12
Q3.23
N/A
-0.30
vs -0.15
Q4.23
N/A
-0.32
vs -0.10
Q1.24
N/A
-0.10
vs -0.08
Q2.24
+114%
0.04
vs -0.29
Q3.24
N/A
-0.12
vs -0.30
Q4.24
+103%
0.01
vs -0.32
Q1.25
N/A
-0.32
vs -0.10
Q2.25
N/A
-0.47
vs 0.04
Sales Growth
YoY
Current
Estimates
Q3.22
NA
NA vs NA
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
NA
NA vs NA
Return on Equity
QoQ
Q1.23
-24%
-0.24
vs -0.22
Q2.23
-19%
-0.19
vs -0.24
Q3.23
-23%
-0.23
vs -0.19
Q4.23
-28%
-0.28
vs -0.23
Q1.24
-10%
-0.10
vs -0.28
Q2.24
+4%
0.04
vs -0.10
Q3.24
-14%
-0.14
vs 0.04
Q4.24
+0%
0
vs -0.14
Institutionnal Ownership
QoQ
Q1.23
9
9
vs 8
13%
Q2.23
7
7
vs 9
-22%
Q3.23
5
5
vs 7
-29%
Q4.23
7
7
vs 5
40%
Q1.24
7
7
vs 7
NA
Q2.24
6
6
vs 7
-14%
Q3.24
6
6
vs 6
NA
Q4.24
30
30
vs 6
400%
seekingalpha.com
6 hours ago
globenewswire.com
6 hours ago
seekingalpha.com
12 hours ago
Relative Strength
DRUG
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2025-EPS
Analyst rating
Price Target
80.00(149.53%)
Number of analyst
1
Last analyst upgrade/downgrade
Cantor Fitzgerald
initialisePrevious: Not converted
2025-01-10
Now: Overweight
H.C. Wainwright
initialisePrevious: Not converted
2025-01-10
Now: Buy
Quote Panel
Key Metrics